Ariana® Pharma teams together with SIB Swiss Institute of Bioinformatics to discover novel biomarkers for gastric cancer

Ariana Pharma, developer of innovative clinical data analysis and diagnostic solutions for the healthcare sector, and SIB Swiss Institute of Bioinformatics, a world-class provider of bioinformatics resources and expertise, today announced their collaboration focusing on the discovery of novel biomarkers for gastric cancer.

This collaboration aims at developing early detection tools for gastric cancer, one of the deadliest cancers.
Read more in English
Read more in French